INTRODUCTION
Hepatitis C virus (HCV) is a single-stranded RNA virus that infects both the liver and lymphoid cells [1, 2] . HCV infection has a strong tendency to evolve to chronicity and often progresses to cirrhosis and eventually to hepatocellular carcinoma [3, 4] . The mechanisms by which this virus establishes such a high rate of persistent infection are still poorly understood. Some evidence suggests that the alteration in the interferon (IFN) system may be involved in the chronicity of this infection [5] . In addition, the function of peripheral blood lymphoid cells has been closely related to viral load [6, 7] .Treatment with recombinant IFN-a2, which is the current therapy, leads to sustained viral clearance only in a small proportion of treated patients [8] .
Human IFN-a comprises a family of extracellular signalling cytokines which confer resistance to viral infection [9±11] and have antiproliferative and immunomodulatory activities [12, 13] . In a previous publication we described that in patients with chronic hepatitis C, IFN-a gene expression is downregulated in the liver but upregulated in peripheral blood mononuclear cells (PBMC) [14] . Since HCV can infect lymphoid cells [2] and these cells play an important role in the clearance of viral infection, we decided to analyse the interferon responsive factors (IRF) and the expression of speci®c IFN-a subtypes in PBMC from HCV infected patients.
IRF-1 and IRF-2 belong to a family of DNA-binding proteins which regulate interferon genes and interferoninducible genes [15, 16] . They bind to the same DNA element where IRF-1 acts as a positive regulator and IRF-2 is as a negative transcription factor that lacks the transactivation domain [17] . The increase in the IRF-1/IRF-2 ratio seems to be a critical event in the transcriptional activation of IFN and subsequent development of the cellular antiviral response [18, 19] .
IFN-a proteins are encoded by a multigene family comprising 13 intronless genes which show 78±94% homology at the nucleotide level [20] and are clustered in human chromosome 9 [21] . Individual IFN-a genes seem to be differentially expressed depending on the stimulus and on the producer cell type [15, 22] . The biological signi®cance of the large abundance of IFN-a genes is not clear. Although all IFN-a subtypes bind to a common receptor, several reports suggest that they show quantitatively distinct patterns of antiviral, growth inhibitory and immunomodulatory activities [23±25] . A combination of different IFN-a subtypes has been found in normal human unstimulated PBMC [14,26±28] and in Sendai virus-induced human PBMC [26, 27, 29] . However the expression of the different IFN-a subtypes in human viral infections has been poorly studied.
In the present report we demonstrate that the interferon system is activated in PBMC from HCV infected patients. In addition we show that while IFN-a5 seems to be induced in PBMC in HCV infection, IFN-a8 is the subtype produced by human PBMC in response to Sendai virus.
MATERIALS AND METHODS

Patients
We analysed PBMC samples from 41 patients with chronic hepatitis C. When diagnosed, chronic hepatitis C patients had raised serum transaminases for more than 6 months, positivity for anti-HCV antibodies (ELISA second-generation, Ortho Diagnostic System, Raritan, NJ, USA), presence of HCV-RNA by RT-PCR in serum and histological evidence of chronic hepatitis. Other causes of chronic hepatitis were excluded. Twelve patients were sustained responders to interferon treatment (persistent normal serum transaminases and negative HCV-RNA in serum for at least 10 months after completion of 1 years IFN treatment) when studied. None of the patients had received treatment with IFN-a in the 10-month period prior to the study. Table 1 shows the biochemical, histological and virological characteristics of the patients.
As controls, a group of 41 healthy volunteers (20 male, 21 female, age range from 24 to 55 years) were studied.
Detection, quanti®cation and genotyping of HCV-RNA was performed as previously described [30] .
Cell culture and stimulation
) resuspended in 5 mL of RPMI 1640 medium (Bio-Whittaker, Verviers, Belgium), supplemented with 1% of fetal calf serum and penicillin-streptomycin (100 U and 100 lg/mL, respectively), were incubated for 6 h at 37°C and 5% CO 2 with or without 16 haemagglutination units per mL of Sendai virus. Following induction, PBMC were pelleted, washed once in 0.9% NaCl and lysed in Ultraspec (Biotecx, Houston, TX, USA). The samples were stored at )80°C until extraction of total RNA, which was performed according to the methods of Chomczynski and Sacchi [31] .
Simultaneously, other aliquots of 5´10 6 As an internal control for each sample, PCR ampli®cation of a fragment of b-actin cDNA (using 6 lL aliquot of the cDNA pool) was performed. IFN-a cDNA fragments were ampli®ed by 20 cycles (94°C, 60°C and 72°C, 1 min per step) and b-actin fragments were ampli®ed by 20 cycles (94°C, 55°C and 72°C, 1 min per step) a protocol that avoided interference of the plateau effect. We used universal primers designed to amplify all IFN-a subtypes. Oligonucleotides (5¢±3¢) d(TCCATGAGATGATCCAGCAG) and d(ATTTCTGCTCTGACAACCTCCC) were the upstream and downstream primers, respectively, for ampli®cation of 274 base pair (bp) fragment from human IFN-a cDNA [20] that is located between nucleotides 240±514 [32] . Primers were designed to obtain the same ampli®cation ef®ciency for all IFN-a subtypes. The two primers correspond to the two most conserved regions among all subtypes. The sequence for annealing of the downstream primer is identical for all of them. The annealing sequence of the upstream primer is the same for subtypes 2, 4, 5, 7, 8, 10, 16, 17 and 21 and it differs in only one nucleotide in subtypes 1, 14 and 22 (this change does not occur in the 3¢ end of the primer). d(TCTACAATGAGCTGCGTGTG) and d(GGTGAGGATCTT-CATGAGGT) were the primers used for ampli®cation of a 314-bp fragment (nucleotides 1319±2079) from the reported human b-actin gene sequence [33] . After PCR ampli®cation, 20 lL aliquots of the PCR reactions were electrophoresed in 2% agarose gel stained with ethidium bromide, and bands were visualized with an UV lamp. Equal size bands were excised and radioactivities were determined. Obtained values were corrected with background radioactivity from blank reactions with no RNA. Finally, values corresponding to IFN-a mRNA were normalized to those of b-actin mRNA and results were expressed as cpm ratio of IFN-a to b-actin. b-Actin is used as internal control because we have previously shown that b-actin mRNA is constantly expressed in PBMC of healthy controls and patients with chronic hepatitis C [30] .
Validation experiments on PCR assays using known quantities of total RNA showed linearity of the counts of ampli®cation bands from 0.125 to 1 lg for IFN-a and b-actin. Thus 0.3 lg for IFN-a and b-actin, respectively, were chosen as a suitable amount of total RNA to avoid the plateau effect. The coef®cient of interassay variation for IFNa/b-actin was 15%. The identity of the PCR product from IFN-a cDNA ampli®cation was veri®ed by automatic sequencing (ABI PRISMä 310 Genetic Analyser, Perkin Elmer).
The identi®cation of IFN-a subtype transcripts was performed by cloning the RT-PCR products using the TOPO TA cloning kit (Invitrogen, Carlsbad, CA, USA). Clones from each insert were sequenced in ABI PRISM TM 310 Genetic
Analyser (Perkin Elmer) using the dye Rhodamine terminator cycle sequencing kit (Perkin Elmer).
Analysis of IFN-a protein
To quantify IFN-a protein levels in PBMC supernatants of unstimulated and Sendai virus-stimulated PBMC, we used an ELISA (Cytosceenä, Biosource International, Camarillo, CA, USA) using speci®c antihuman IFN-a antibodies. The assay was performed following the instructions of the manufacturers. The sensitivity limit of the assay was 25 pg/mL.
Analysis of IRF-1 and IRF-2 mRNA levels
Estimation of IRF-1 and IRF-2 mRNA levels was carried out using previously described RT-PCR methodology. Total RNA from PBMC was reverse-transcribed (0.2 and 0.3 lg for IRF-1 and IRF-2, respectively) and the cDNA pool was used for PCR ampli®cation, as above, but using 200 ng for each IRF-1 and IRF-2 upstream and downstream primers. b-Actin was also used as an internal control for each sample. IRF-1 and IRF-2 cDNA fragments were ampli®ed by 19 and 28 cycles, respectively (94°C, 55°C and 72°C, 1 min per step), to avoid the plateau effect. Oligonucleotides d(CTGA-TACCTTCTCTGATGG) and d(TCCAGGTTCATTGAGTAGG) were the upstream and downstream primers used to amplify a 353-bp fragment from human IRF-1 cDNA, that is located between nucleotides 631±983 [34] . d(TTTTCAGATCC-CCTGGATGC) and d(TCAGTGGTGACCTCTACAAC) were the primers used for ampli®cation of 525 bp fragment from human IRF-2 cDNA that is located between nucleotides 197±721 [35] . Validation experiments of PCR assays using known quantities of total RNA (from 0 to 1 lg) were carried out, and 0. the curve. The coef®cient of interassay variation for IRF-1/ b-actin and IRF-2/b-actin was 7.5% and 14%, respectively. The identity of the PCR product from IRF-1 and IRF-2 cDNA ampli®cation was further veri®ed by enzymatic digestion. We used EcoO109 I (for IRF-1) and EcoR I (for IRF-2) that yielded the predicted restriction fragments, while Sac I did not digest the ampli®ed PCR products (no restriction sites for this endonuclease are present in the ampli®ed regions).
Statistical analysis
Results of IFN-a, IRF-1 and IRF-2 are given as mean standard errors of the mean. Normality was assessed with the Shapiro±Wilks' test. Statistical analysis of IFN-a, IRF-1 and IRF-2 levels in PBMC were performed using nonparametric test (Kruskal±Wallis and Mann±Whitney U-tests). Associations between quantitative variables were studied with Spearman's correlation coef®cient. IFN-a subtypes expressed in PBMC, before and after Sendai virus stimulation, were analysed with Wilcoxon test. All P-values were two-tailed. SPSS 6.0 for Windows was used for the statistical analysis.
RESULTS
Expression of interferon regulatory factors in PBMC from normal subjects and patients with present and past HCV infection
We have previously demonstrated that the values of IFN-a mRNA in unstimulated PBMC from HCV-RNA positive patients was higher than healthy controls [14] . To further analyse the activation of the interferon system in PBMC we have now determined the level of IRF-1 and IRF-2 gene expression in healthy subjects, patients with chronic hepatitis C and in patients who cleared HCV infection after IFN therapy. We found that in unstimulated PBMC, IRF-1 mRNA levels (Fig. 1a) and the IRF-1/IRF-2 ratio (Fig. 1b) were higher in HCV-RNA positive patients than in healthy controls. Patients with sustained complete virological and biochemical response after IFN therapy showed IRF-1 mRNA levels (Fig. 1a) and IRF-1/IRF-2 ratio similar to healthy controls (Fig. 1b) . The levels of IRF-2 mRNA were comparable in the three groups studied (0.67 0.06; 0.87 0.07 and 0.85 0.1; healthy controls, HCV-RNA (+) patients and HCV-RNA (±) patients, respectively).
No correlation was observed between IRF-1 or IRF-2 levels and serum transaminases nor between IRF-1 or IRF-2-values and liver damage as estimated in liver biopsies by the Knodell's score of histological activity. Also no correlation was found between IRF-1 or IRF-2 mRNA levels and viral load as determined by competitive PCR in viraemic patients. Moreover, no differences in IRF-1 or IRF-2 mRNA values were found in patients infected with different HCV genotypes.
The effect of Sendai virus stimulation on IFN-a, IRF-1 and IRF-2 gene expression in PBMC from healthy controls, patients with chronic hepatitis C and patients who cleared HCV after interferon therapy Sendai virus stimulation led to a signi®cant increase in the levels of IRF-1, IRF-2 and IFN-a mRNA in PBMC with respect to basal values in healthy controls as well as in patients with present and past HCV infection (Table 2) . Stimulated IRF-1, IRF-2 and IFN-a mRNA levels were similar in the three groups studied ( Table 2) .
We also measured IFN-a protein in supernatants from PBMC with and without Sendai virus stimulation. IFN-a protein could not be detected in supernatants from unstimulated PBMC in any of the three groups studied. After Sendai virus stimulation IFN-a protein increased to similar values in all groups (17 600 2223; 12 616 1572 and 19 348 4766 pg/mL in healthy controls, HCV-RNA positive and HCV-RNA negative patients, respectively).
Expression of IFN-a subtypes in PBMC
The IFN-a cDNAs generated by RT-PCR were cloned and sequenced. In unstimulated PBMC, we studied 75 clones from eight healthy subjects and 83 clones from eight patients with chronic hepatitis C. We found a broad spectrum of IFN-a subtypes in both healthy controls and HCV-RNA positive patients. IFN-a5, IFN-a1 and IFN-a21 were the main subtypes, comprising nearly 80% of total IFN-a in unstimulated PBMC from healthy subjects. In patients with HCV infection, as compared to normal controls, we found a signi®cant increase in the expression of IFN-a5 (P < 0.05) which represented 65% of all sequenced clones (Table 3) .
Five patients and ®ve controls were also studied after Sendai virus stimulation. As shown in Table 4 , after Sendai virus stimulation, a mixture of different IFN-a subtypes were expressed in both patients and controls. IFN-a1, IFN-a8, IFN-a2 and IFN-a5 were the major subtypes expressed in healthy controls, comprising 82.8% of total IFN. IFN-a1, IFN-a8 and IFN-a2 were the major subtypes expressed in HCV-RNA positive patients, comprising 79% of total IFN. IFN-a8 was the only IFN-a subtype which increased signi®-cantly in both, healthy controls (P < 0.05) and HCV-RNA positive patients (P < 0.05). The expression of IFN-a5 subtype decreased signi®cantly after Sendai virus stimulation in HCV positive patients (P < 0.05). This subtype also tended to decrease after Sendai virus infection in healthy controls but in these subjects the differences were not statistically signi®cant.
DISCUSSION
Both the activation of the interferon system and the speci®c antiviral T-cell immunity, measured in peripheral blood mononuclear cells, appear to be important in the control of -1, IRF-2 and IFN-a mRNA levels (as a ratio to b-actin b Nd, no detectable (mRNA of IFN-a was no detectable using 20 cycles of PCR ampli®cation, which is the number of cycles used to quantify IFN-a mRNA in Sendai virus stimulated PBMC to avoid interferences with the plateau effect. IFN-a mRNA in unstimulated PBMC was detectable after 30 cycles of ampli®cation). * P < 0.05 Sendai virus stimulated vs. unstimulated PBMC. HCV infection [7, 36] . This report shows that the IFN system is activated in mononuclear cells from HCV-infected patients. Recently, a more relevant role for other members of the IRF family, such as IRF-3 and IRF-7, has been described in viral infections [43, 44] . IRF-1 is stimulated not only by viral infection of the cells but also by cytokines such as interferongamma and IL-12 [45, 46] . Since IFN-c is elevated in HCV infection [47, 48] this might contribute to the high levels of IRF-1 seen in this disease.
To further analyse whether the interferon machinery of PBMC responded normally to stimulation in patients with chronic hepatitis C, we investigated the changes in IFN-a and IRFs transcripts and the production of IFN-a protein after in vitro stimulation of PBMC with Sendai virus. We found that HCV infection did not result in disturbed inducibility of IRFs genes nor of IFN-a production. These ®ndings are in contrast with those reported in patients with HBV or HIV infections where the IFN system is impaired in PBMC [49±50] .
Very few studies have explored the role of the different IFN-a subtypes in viral infections in humans. In 1987, Tovey et al. using RNA blot hybridization showed that IFN-a could be detected in the apparent absence of induction [51] . Another study performed by Greenway and coworkers detected IFN-a in the cytoplasm of PBMC, in the absence of viral stimulation, by immuno¯uorescence using polyclonal antipeptide antisera [27] . A similar ®nding was reported by Brandt et al. using the polymerase chain reaction with universal primers and with selected subtype speci®c primers [26] . Lallemand et al. found that IFN-a5 was the main subtype expressed in PBMC using PCR technique followed by direct dideoxy sequencing [28] . The availability of automatic sequencing after cloning the RT-PCR product, allowed us to perform a more complete analysis of the IFN-a subtypes expressed in normal PBMC. We have found that IFN-a5, IFN-a1 and IFN-a21 are the main IFN-a subtypes constitutively expressed in unstimulated PBMC from healthy controls. The constitutive expression of IFN-a has been related to the maintenance of HLA proteins on the cell surface [28] . In chronically HCV-infected cells we found a signi®cant and selective increase of IFN-a5 subtype.
Interestingly, IFN-a5 which is the only subtype expressed in normal liver tissue [14] and the main subtype in normal pancreas [52] , is reduced in the liver from HCV infected patients [14] . In HCV infection the liver is the main site of viral replication and low levels of IFN-a5 may favour persistent HCV infection of this organ. PBMC (with higher Table 4 IFN-a subtypes in peripheral blood mononuclear cells from normal controls (C) and patients with chronic hepatitis C (P) before and after Sendai virus stimulation Tested clones  a1  a2  a4  a5  a7  a8  a10  a14  a16  a17  a21  a22   C1  12*-10  0±4  0±1  0±0  8±0  0±0  1±2  0±3  0±0  0±0  0±0  3±0  0±0  C2  8±12  0±6  2±3  0±0  4±1  0±0  0±2  1±0  0±0  1±0  0±0  0±0  0±0  C3  8±8  2±1  0±0  0±0  3±2  0±0  0±2  0±1  0±0  0±2  0±0  2±0  1±0  C4  7±11  0±2  1±0  1±0  1±3  1±0  1±4  2±0  0±1  0±0  0±0  0±1  0±0  C5  12±11  0±3  1±3  0±0  8±1  0±0  0±3  0±0  0±0  0±0  0±0  3±1  0±0   Total  47±52  2±16 4±7  1±0  24±7  1±0  2±13à 3±4  0±1  1±2  0±0  8±2  1±0   P1  10±12  2±6  0±1  0±0  7±2  0±1  1±2  0±0  0±0  0±0  0±0  0±0  0±0  P2  12±9  2±1  0±2  0±0  6±1  2±0  0±3  0±0  0±0  0±1  0±1  2±0  0±0  P3  11±12  0±2  1±2  0±0  10±0  0±2  0±4  0±1  0±0  0±0  0±0  0±1  0±0  P4  10±12  0±6  0±2  0±0  8±1  0±0  0±3  0±0  0±0  0±0  0±0  2±0  0±0  P5  11±12  2±5  0±0  0±0  7±0  0±0  2±6  0±1  0±0  0±0  0±0  0±0 levels of IFN-a5 transcripts) may act as a reservoir for HCV but these cells allow HCV replication at levels considerably lower than in the liver [2] . Further studies using quantitative PCR speci®c for IFN-a5 are needed to determine whether the levels of this IFN-a subtype can correlate with the replicative activity of the virus.
In contrast to what happens in natural HCV infection, in vitro infection with Sendai virus selectively upregulates IFN-a8 in both normal subjects and HCV infected patients cells. It has been reported that monocytes and the so called natural IFN-producing cells' (NIPC), which are thought to be dendritic cells, are the two major IFN-a producing cells in PBMC [53] . IFN-a production in response to Sendai virus occurs predominantly in monocytes, whereas most enveloped viruses stimulate NIPC [54] . IFN-a produced by virus-activated IFN-producing cells contributes to the differentiation of these cells into dendritic cells [55] . If the different IFN subtype expression we detected re¯ects selective IFN-a production by different PBMC subpopulations and whether it has a role in the altered function of dendritic cells in patients with HCV [56] needs to be studied.
In summary, the interferon system is activated in PBMC from subjects with chronic HCV infection. The response of PBMC to in vitro stimulation with Sendai virus is preserved in chronic hepatitis C. While Sendai virus induces preferentially IFN-a8 in both patients and healthy controls, HCV infection of PBMC is associated with IFN-a5 subtype expression. The role of IFN-a5 in the control of HCV infection should be investigated.
